Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001022701 | SCV001184468 | likely benign | Hereditary cancer-predisposing syndrome | 2019-02-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001414001 | SCV001616125 | likely benign | Tuberous sclerosis 2 | 2021-10-17 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001414001 | SCV002039489 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004003199 | SCV004826751 | likely benign | Tuberous sclerosis syndrome | 2023-04-28 | criteria provided, single submitter | clinical testing |